Loading…
Based on limited metadata, this Warning Letter was issued to Tris Pharma Inc., a pharmaceutical manufacturer, on March 26, 2018. Without access to the full letter text or subject line, the specific nature of the violations cannot be determined from the available information. The letter addresses compliance issues related to pharmaceutical products, though the particular product category and specific regulatory requirements in question are not detailed in the metadata provided. To understand the full scope and nature of the violations, the complete Warning Letter would need to be reviewed.